financetom
Business
financetom
/
Business
/
CGI Meets Expectations With Q2 Earnings, but Flags Higher Restructuring Costs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CGI Meets Expectations With Q2 Earnings, but Flags Higher Restructuring Costs
May 25, 2025 9:49 PM

07:09 AM EDT, 04/30/2025 (MT Newswires) -- CGI (GIB-A.TO, GIB), an IT and business consulting services company, shed 1% in U.S. pre-market trading on Wednesday as it reported in-line earnings for the second quarter while flagging higher restructuring costs to come.

For Q2, CGI posted adjusted earnings per share of $2.12, meeting a FactSet estimate. Revenue came in at $4.02 billion compared with a FactSet estimate of $4 billion.

Among other highlights, the company cited cash provided by operating activities of $438.2 million, representing 10.9% of revenue; bookings of $4.48 billion, for a book to bill ratio of 111.5% or 110.6% on a trailing 12-month basis; and backlog of $30.99 billion or 2.0 times annual revenue.

The board approved a quarterly cash dividend for Class A subordinate voting shares and Class B shares of $0.15 per share. The dividend is payable on June 20 to shareholders of record May 16.

"We remain in constant dialogue with our clients regarding the evolving business dynamics they are facing. To remain strong, we regularly assess these dynamics and take proactive actions to expand shareholder value for the benefit of our stakeholders," said Francois Boulanger, president and CEO. "As such, CGI increased the scope of our previously announced restructuring program, most of which continues to be targeted within our Continental Europe operations."

He noted CGI incurred $44.2 million of costs this quarter and expects to incur an additional $137.0 million to implement these actions over the next few quarters.

CGI rose 1.1% on the TSX yesterday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves Roche's drug for a chronic blood disorder (June 21)
US FDA approves Roche's drug for a chronic blood disorder (June 21)
Jun 24, 2024
June 21 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab, branded as PiaSky, is a monthly under-the-skin or intravenous treatment for paroxysmal nocturnal hemoglobinuria (PNH). PNH is a disorder in which red blood cells break apart prematurely. It can cause anemia, fatigue and...
Germany's Aareal to reap $2.1 bln gain in sale of Aareon to TPG consortium
Germany's Aareal to reap $2.1 bln gain in sale of Aareon to TPG consortium
Jun 24, 2024
FRANKFURT, June 24 (Reuters) - German property lender Aareal Bank will book a gain of around 2 billion euros ($2.14 billion) after it sells its tech unit Aareon to private equity firm TPG and investor CDPQ, it said in announcing the deal on Monday. Aareal, based in Germany but operating globally, said it would only realize the gain later this...
Prudential Launches $2 Billion Share Buyback, Commences First $700 Million Tranche
Prudential Launches $2 Billion Share Buyback, Commences First $700 Million Tranche
Jun 24, 2024
05:37 AM EDT, 06/24/2024 (MT Newswires) -- Prudential (PUK) said Sunday it has launched a $2 billion share buyback program and is starting the first $700 million tranche. The overall buyback program will end no later than the middle of 2026. Under the terms of the buyback, which was granted shareholder approval at the company's 2024 annual general meeting, the...
Italy's Eni likely to finalise Enilive stake sale by year-end, CEO says
Italy's Eni likely to finalise Enilive stake sale by year-end, CEO says
Jun 24, 2024
(Corrects third paragraph to show that the 1.3 billion euros is for stakes in Enilive and Novamont, not only Enilive) ROME (Reuters) -Italian energy group Eni expects to complete the sale of a minority stake in its biofuel unit Enilive by the end of 2024, Chief Executive Claudio Descalzi said on Monday. The (sale) plan is in progress, there are still issues that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved